Evaluation of patient-related factors associated with causality, preventability, predictability and severity of hepatotoxicity during antituberclosis treatment

Preventability and severity assessment in reporting adverse drug reactions

Steven C. Hartwig, Jerry Siegel, Philip J. Schneider · American Journal of Health-System Pharmacy · 1992 · 915 citations

Pharmacotherapy, Ohio State University, Journal Article Preventability +18

Incidence of Serious Side Effects from First-Line Antituberculosis Drugs among Patients Treated for Active Tuberculosis

Daphne Yee, Chantal Valiquette, Marthe Pelletier et al. · American Journal of Respiratory and Critical Care Medicine · 2003 · 833 citations

Drug Safety, Compromise Treatment, Pulmonary Tuberculosis +15

Focusing on the preventability of adverse drug reactions.

Glen T. Schumock, John P. Thornton · PubMed · 1992 · 608 citations

Drug Safety, Drug Hypersensitivity, Adverse Drug Reactions +8

Risk factors for side-effects of isoniazid, rifampin and pyrazinamide in patients hospitalized for pulmonary tuberculosis

T. Schaberg, K Rebhan, H. Lode · European Respiratory Journal · 1996 · 379 citations · Full text

Pulmonary Tuberculosis, Health Sciences, Medicine +12

Evaluation of Clinical and Immunogenetic Risk Factors for the Development of Hepatotoxicity during Antituberculosis Treatment

Surendra K. Sharma, Arumugam Balamurugan, Pradip Kumar Saha et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 333 citations

Immunology, Genetic Epidemiology, Pathology +22